Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival

Journal of Hepatology

Volumn 64, Issue 2, 2016, Pages 326-332

  Yan, Melissa ^a   Ha, John ^a   Aguilar, Maria ^a   Bhuket, Taft ^a   Liu, Benny ^a   Gish, Robert G ^b   Cheung, Ramsey ^b,c   Wong, Robert J ^a  

^a HIGHLAND HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Hepatitis C virus; Liver cancer; SEER

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HEALTH DISPARITY; HUMAN; LIVER CELL CARCINOMA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; AGE; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DISEASE MANAGEMENT; HEPATITIS C; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGE FACTORS; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; HEALTH STATUS DISPARITIES; HEPATECTOMY; HEPATITIS C; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; UNITED STATES;

EID: 84954397839     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.09.006     Document Type: Article

References (29)

1. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
2. H.B. El-Serag, and F. Kanwal Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 60 2014 1767 1775
3. S.K. Asrani, and G.L. Davis Impact of birth cohort screening for hepatitis C Curr Gastroenterol Rep 16 2014 381
4. B.D. Smith, G.A. Beckett, A. Yartel, D. Holtzman, N. Patel, and J.W. Ward Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008 Am J Public Health 104 2014 474 481
5. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
6. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 e1261
7. G.L. Davis, M.J. Alter, H. El-Serag, T. Poynard, and L.W. Jennings Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression Gastroenterology 138 2010 513 521 521 e511-516
8. A.J. Sanyal The Institute of Medicine report on viral hepatitis: a call to action Hepatology 51 2010 727 728
9. R.F. Velazquez, M. Rodriguez, C.A. Navascues, A. Linares, R. Perez, N.G. Sotorrios, and et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527
10. J.D. Yang, W.R. Kim, R. Coelho, T.A. Mettler, J.T. Benson, S.O. Sanderson, and et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma Clin Gastroenterol Hepatol 9 2011 64 70
11. H. Hagan, J. Campbell, H. Thiede, S. Strathdee, L. Ouellet, F. Kapadia, and et al. Self-reported hepatitis C virus antibody status and risk behavior in young injectors Public Health Rep 121 2006 710 719
12. D.W. Roblin, B.D. Smith, C.M. Weinbaum, and M.E. Sabin HCV screening practices and prevalence in an MCO, 2000-2007 Am J Managed Care 17 2011 548 555
13. W.N. Southern, M.L. Drainoni, B.D. Smith, C.L. Christiansen, D. McKee, A.L. Gifford, and et al. Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting J Viral Hepatitis 18 2011 474 481
14. P.R. Spradling, L. Rupp, A.C. Moorman, M. Lu, E.H. Teshale, S.C. Gordon, and et al. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence Clin Infect Dis 55 2012 1047 1055
15. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
16. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
17. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2013 Sub (1973-2011) - Linked To County Attributes - Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission.
18. M.D.L. Adamo, and J. Ruhl 2014 SEER program coding and staging manual 2014 National Cancer Institute Bethesda, MD 20850-9765
19. D.B. Rein, J.S. Wittenborn, C.M. Weinbaum, M. Sabin, B.D. Smith, and S.B. Lesesne Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States Digest Liver Dis 43 2011 66 72
20. R.J. Wong, R. Cheung, and A. Ahmed Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S Hepatology (Baltimore, MD) 59 2014 2188 2195
21. A.M. Di Bisceglie, A.C. Lyra, M. Schwartz, R.K. Reddy, P. Martin, G. Gores, and et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status Am J Gastroenterol 98 2003 2060 2063
22. A. Koteish, and P.J. Thuluvath Screening for hepatocellular carcinoma J Vasc Intervent Radiol 13 2002 S185 190
23. R. Wong, and D.A. Corley Racial and ethnic variations in hepatocellular carcinoma incidence within the United States Am J Med 121 2008 525 531
24. A. Artinyan, B. Mailey, N. Sanchez-Luege, J. Khalili, C.L. Sun, S. Bhatia, and et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States Cancer 116 2010 1367 1377
25. A.K. Mathur, N.H. Osborne, R.J. Lynch, A.A. Ghaferi, J.B. Dimick, and C.J. Sonnenday Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma Arch Surg 145 2010 1158 1163
26. R.J. Wong, and D.A. Corley Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States Dig Dis Sci 54 2009 2031 2039
27. A.B. Siegel, R.B. McBride, H.B. El-Serag, D.L. Hershman, R.S. Brown Jr., J.F. Renz, and et al. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002 The American journal of gastroenterology 103 2008 120 127
28. D. Sloane, H. Chen, and C. Howell Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival J Natl Med Assoc 98 2006 1934 1939
29. C.J. Sonnenday, J.B. Dimick, R.D. Schulick, and M.A. Choti Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma J Gastrointest Surg 11 2007 1636 1646 [discussion 1646]